The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy in De-Novo Heart Transplant Recipients: Results of the Schedule Trial after 6 Years

被引：0
|
作者：
Arora, S. [1 ]
Karason, K. [2 ]
Gustafsson, F. [3 ]
Eiskjaer, H. [4 ]
Radegran, G. [5 ]
Aaberge, L. [1 ]
Gude, E. [1 ]
Solbu, D. [6 ]
Dellgren, G. [2 ]
Andreassen, A. K. [1 ]
Gullestad, L. [1 ]
机构：
[1] Natl Hosp Norway, Oslo Univ Hosp, Cardiol, Oslo, Norway
[2] Sahlgrens Univ Hosp, Cardiol, Gothenburg, Sweden
[3] Copenhagen Univ Hosp, Cardiol, Copenhagen, Denmark
[4] Skejby Univ Hosp, Cardiol, Aarhus, Denmark
[5] Skane Univ Hosp, Cardiol, Lund, Sweden
[6] Novartis Norge, Oslo, Norway
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2018年 / 37卷 / 04期
关键词：
D O I：
10.1016/j.healun.2018.01.069
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
67
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [41] Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients (vol 7, pg 567, 2020)
    Bergh, Niklas
    Gude, Einar
    Bartfay, Sven-Erik
    Andreassen, Arne K.
    Arora, Satish
    Dahlberg, Pia
    Dellgren, Goran
    Gullestad, Lars
    Gustafsson, Finn
    Karason, Kristjan
    Radegran, Goran
    Bollano, Entela
    Andersson, Bert
    [J]. ESC HEART FAILURE, 2021, 8 (04): : 3449 - 3449
  • [42] De Novo Heart Transplant Recipients at Increased Risk of Cardiac Allograft Vasculopathy: IVUS Analysis of Specific Subpopulations Treated with Everolimus Versus MMF
    Starling, R.
    Pauly, D.
    Wang, S.
    Cantin, B.
    Ross, H.
    Burton, J.
    Eisen, H. J.
    Keogh, A.
    Dong, G.
    Jiang, H.
    Cines, M.
    Lopez, P.
    Kobashigawa, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 132 - 132
  • [43] Efficacy and Safety of Everolimus with Reduced-Dose Calcineurin Inhibitor in De Novo Kidney Transplant Recipients: Results from the TRANSFORM Study
    Pascual, Julio
    Chadban, Steve
    Tedesco, Helio
    Berger, Stefan
    Qazi, Yasir
    Cruzado, Josep M.
    Bernhardt, Peter
    Legendre, Christophe
    Kim, Myoung Soo
    Vincenti, Flavio
    [J]. TRANSPLANTATION, 2018, 102 : S367 - S368
  • [44] Early Converison of Calcineurin Inhibitor to Everolimus in De Novo Renal Transplant Recipients and Its Impact on Cardiovascular Parameters: The ELEVATE Study Design
    van der Giet, M.
    de Fijter, J. W.
    Holdaas, H.
    Legendre, C.
    Neumayer, H. H.
    Machein, U.
    Junge, G.
    Cruzado, J. M.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 991 - 991
  • [45] Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial
    Budde, Klemens
    Becker, Thomas
    Arns, Wolfgang
    Sommerer, Claudia
    Reinke, Petra
    Eisenberger, Ute
    Kramer, Stefan
    Fischer, Wolfgang
    Gschaidmeier, Harald
    Pietruck, Frank
    [J]. LANCET, 2011, 377 (9768): : 837 - 847
  • [46] Optimizing the Safety Profile of Everolimus by Delayed Initiation in De Novo Heart Transplant Recipients: Results of the Prospective Randomized Study EVERHEART
    Potena, Luciano
    Pellegrini, Carlo
    Grigioni, Francesco
    Amarelli, Cristiano
    Livi, Ugolino
    Maccherini, Massimo
    Masciocco, Gabriella
    Faggian, Giuseppe
    della Monica, Paola Lilla
    Gerosa, Gino
    Marraudino, Nicola
    Gorda, Marco
    Boffini, Massimo
    [J]. TRANSPLANTATION, 2018, 102 (03) : 493 - 501
  • [47] Effect of everolimus initiation and early calcineurin inhibitor withdrawal on myocardial FOXP3+regulatory T cells in heart transplantation
    Mirza, Kiran
    Gustafsson, Finn
    Gullestad, Lars
    Arora, Satish
    Andersen, Claus
    [J]. TRANSPLANT IMMUNOLOGY, 2016, 38 : 75 - 77
  • [48] Analysis of Renal Function in Everolimus/Enteric-Coated Mycophenolate Sodium Treated De Novo Renal Transplant Recipients after Calcineurin Inhibitor Withdrawal: The ZEUS Study.
    Budde, K.
    Becker, T.
    Arns, W.
    Sommerer, C.
    Reinke, P.
    Eisenberger, U.
    Fischer, W.
    Kramer, S.
    Pietruck, F.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 259 - 259
  • [49] Renal Function of an Everolimus Based Therapy after Calcineurin Inhibitor Withdrawal in Maintenance Renal Transplant Recipients: 3 Year Data of the APOLLO Trial
    Rath, T.
    Budde, K.
    Sommerer, C.
    Haller, H.
    Suwelack, B.
    May, C.
    Paulus, E. -M
    Witzke, O.
    Reinke, P.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 994 - 994
  • [50] TWO YEAR DATA OF THE APOLLO TRIAL: RENAL FUNCTION OF AN EVEROLIMUS BASED THERAPY AFTER CALCINEURIN INHIBITOR WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS
    Reinke, P.
    Haller, H.
    Rath, T.
    Arns, W.
    Paulus, E. -M.
    Scheidl, S.
    Witzke, O.
    Sommerer, C.
    Budde, K.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 50 - 50
12345